Table A3.
Recurrence per 1,000 Person-Years and Relative Risk in BRAF V600E Mutation–Positive Versus –Negative Patients in Various Tumor Size Groups of PTC (all types)
| Tumor Size Category (cm) | Recurrence |
Relative Risk | 95% CI | |||
|---|---|---|---|---|---|---|
|
BRAF Mutation Positive |
BRAF Mutation Negative |
|||||
| Per 1,000 Person-Years | 95% CI | Per 1,000 Person-Years | 95% CI | |||
| 1.0 to 2.0 | 31.71 | 25.00 to 40.22 | 18.36 | 13.47 to 25.03 | 1.73 | 1.17 to 2.55 |
| 2.0 to 3.0 | 45.33 | 35.20 to 58.39 | 27.36 | 19.82 to 37.76 | 1.66 | 1.10 to 2.50 |
| 3.0 to 4.0 | 64.02 | 48.39 to 84.71 | 46.48 | 33.21 to 65.05 | 1.38 | 0.89 to 2.13 |
| ≥ 4.0 | 91.92 | 70.57 to 119.73 | 49.28 | 34.25 to 70.92 | 1.87 | 1.19 to 2.92 |
Abbreviation: PTC, papillary thyroid cancer.